The spike protein technology co-developed by Professor Jason McLellan, Texas Biologics Executive Committee member, is used in many leading vaccines, including Pfizer/BioNTech, Moderna, Johnson & Johnson, and Novavax. To date, hundreds of millions of people across the globe have been immunized against COVID-19 with vaccines that use this patented technology.
Researchers at UT continue to develop advanced vaccines and technologies to address the next global pandemic. Some of the ongoing development work in our labs includes vaccines to prevent infection from a range of infectious diseases, including:
- Pertussis (Whooping Cough)
- Crimean-Congo Hemorrhagic Fever Virus (CCHFV)
- Influenza
- Malaria
- Norovirus
- Human Metapneumovirus (hMPV) and Human Cytomegalovirus (HCMV)